SCHEMBL24314285

SCHEMBL24314285

CC(C)c1ccc(OC2CCC2)c(S(=O)(=O)Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.41
▸ PDE4A P27815 5/20 0.39
▸ PDE4B Q07343 4/20 0.39
▸ PDE4C Q08493 2/20 0.39
▸ PDE4D Q08499 2/20 0.39
▸ TRPV4 Q9HBA0 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ POLB P06746 1/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ RECQL P46063 1/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CNR2 P34972 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22588464 0.86 P2RX4 (0.43) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL29469834 0.79 CA1 (0.41) ALDH1A1PDE4BSMN1; SMN2
SCHEMBL13678369 0.78 CSNK2A1 (0.51) PDE4ANPSR1HTR2CHTR2BHPGD
SCHEMBL31372170 0.78 CSNK2A1 (0.43) PDE4APDE4BPDE4CPDE4DPOLB
SCHEMBL10641518 0.77 ALDH1A1 (0.57) ALDH1A1TRPV4SMN1; SMN2POLBNPSR1
SCHEMBL29469921 0.77 ALDH1A1 (0.44) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL24313728 0.77 ALDH1A1 (0.44) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL13450374 0.76 PDE4A (0.40) ALDH1A1PDE4APDE4BSMN1; SMN2NPSR1
SCHEMBL13499052 0.75 CSNK2A1 (0.55) PDE4ANPSR1HTR2CHTR2BHPGD
SCHEMBL24313936 0.75 HTR2C (0.40) PDE4APDE4BPDE4CPDE4DNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 — — WO disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 — — WO disclosed
Send feedback